Healthcare -
Biotechnology - NASDAQ - US
$ 1.205
2.12 %
$ 94.7 M
Market Cap
-1.8
P/E
SLS - OTHER CURRENT LIABILITIES
Other Current Liabilities SLS - SELLAS Life Sciences Group, Inc.
7.65 M
LAST VALUE
76.99%
2 YEAR CAGR
28.09%
5 YEAR CAGR
-18.28%
10 YEAR CAGR